These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32599587)

  • 1. Caffeine and Its Pharmacological Benefits in the Management of Androgenetic Alopecia: A Review.
    Völker JM; Koch N; Becker M; Klenk A
    Skin Pharmacol Physiol; 2020; 33(3):93-109. PubMed ID: 32599587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a cosmetic phyto-caffeine shampoo in female androgenetic alopecia.
    Bussoletti C; Tolaini MV; Celleno L
    G Ital Dermatol Venereol; 2020 Aug; 155(4):492-499. PubMed ID: 29512972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia.
    Dhurat R; Chitallia J; May TW; Jayaraaman AM; Madhukara J; Anandan S; Vaidya P; Klenk A
    Skin Pharmacol Physiol; 2017; 30(6):298-305. PubMed ID: 29055953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for supplemental treatments in androgenetic alopecia.
    Famenini S; Goh C
    J Drugs Dermatol; 2014 Jul; 13(7):809-12. PubMed ID: 25007363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of phosphodiesterase inhibitors for the treatment of alopecia.
    Juhász MLW; Atanaskova Mesinkovska N
    J Dermatolog Treat; 2020 May; 31(3):245-253. PubMed ID: 30935254
    [No Abstract]   [Full Text] [Related]  

  • 7. Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
    Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
    Marotta JC; Patel G; Carvalho M; Blakeney S
    Int J Pharm Compd; 2020; 24(1):69-76. PubMed ID: 32023218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Off-Label Topical Treatments for the Management of Androgenetic Alopecia: A Review.
    Gupta AK; Mays RR; Versteeg SG; Shear NH; Piguet V; Piraccini BM
    Clin Drug Investig; 2019 Mar; 39(3):233-239. PubMed ID: 30652260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia.
    Watanabe Y; Nagashima T; Hanzawa N; Ishino A; Nakazawa Y; Ogo M; Iwabuchi T; Tajima M
    Int J Cosmet Sci; 2015 Dec; 37(6):579-87. PubMed ID: 25925959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of topical caffeine in male androgenetic alopecia.
    Dressler C; Blumeyer A; Rosumeck S; Arayesh A; Nast A
    J Dtsch Dermatol Ges; 2017 Jul; 15(7):734-741. PubMed ID: 28677188
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiology and Medical Treatments for Alopecia.
    Tai T; Kochhar A
    Facial Plast Surg Clin North Am; 2020 May; 28(2):149-159. PubMed ID: 32312501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man.
    Liu X; Grice JE; Lademann J; Otberg N; Trauer S; Patzelt A; Roberts MS
    Br J Clin Pharmacol; 2011 Nov; 72(5):768-74. PubMed ID: 21599723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current management of androgenetic alopecia in men.
    Wolff H; Kunte C
    Eur J Dermatol; 1999 Dec; 9(8):606-9. PubMed ID: 10586125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro.
    Fischer TW; Hipler UC; Elsner P
    Int J Dermatol; 2007 Jan; 46(1):27-35. PubMed ID: 17214716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model of androgenetic alopecia.
    Crabtree JS; Kilbourne EJ; Peano BJ; Chippari S; Kenney T; McNally C; Wang W; Harris HA; Winneker RC; Nagpal S; Thompson CC
    Endocrinology; 2010 May; 151(5):2373-80. PubMed ID: 20233794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.